Impact of systemic parameters before commencing anti-vascular endothelial growth factor therapy for diabetic macular edema – Pan-Indian survey of retina specialists

PURPOSE: Intravitreal anti-vascular endothelial growth factor (VEGF) injection therapy has emerged as the mainstay of treatment in the management of diabetic macular edema (DME) today. Various systemic risk factors have to be considered before initiating anti-VEGF therapy. The aim of our study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugam, P Mahesh, Shah, Payal, Ramanjulu, Rajesh, Mishra, Divyansh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725122/
https://www.ncbi.nlm.nih.gov/pubmed/34708786
http://dx.doi.org/10.4103/ijo.IJO_1178_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725122/
https://www.ncbi.nlm.nih.gov/pubmed/34708786
http://dx.doi.org/10.4103/ijo.IJO_1178_21

Ejemplares similares